Tadocizumab (C4G1; YM-337) is a humanized моноклональный антитело tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.